Forecast for CDT stock

The forecast for Conduit Pharmaceuticals Inc. (CDT) stock is mixed, with both positive and negative signals.

1. Short-term Trend: The short-term trend for CDT stock is negative, with a 30-day percentage change of -18.28% as of August 16, 2024. This decline suggests that the stock is currently under pressure.
2. Moving Averages: The 50-day moving average is $0.79, and the 200-day moving average is $0.98, both of which are below the current trading price of $0.30 as of August 15, 2024. This indicates a bearish trend, as the stock is trading below both short-term and long-term moving averages.
3. Analyst Ratings and Price Targets: There is no available data on analyst ratings or price targets for CDT stock. The absence of such data makes it challenging to gauge the market's expectations and sentiment.
4. Market Sentiment: The sentiment is bearish, with a Fear & Greed Index of 39 (Fear), indicating that investors are fearful and may be selling the stock.
5. Technical Indicators: The stock holds sell signals from both short-term and long-term Moving Averages, suggesting a more negative forecast. Additionally, a pivot bottom point on August 14, 2024, has resulted in a 0% change, indicating a lack of momentum.
6. Long-term Predictions: Long-term predictions for CDT stock are not optimistic, with forecasts suggesting a significant decline in stock price over the next few years. For instance, by 2025, the stock price is projected to be $0.366038, which represents a -97.25% decrease from the current price.
7. Stock Performance: The stock has experienced significant volatility, with a daily average volatility of 7.47% as of August 16, 2024. This volatility, combined with the current bearish trend, suggests that the stock may continue to be volatile.

In conclusion, while the absence of analyst coverage and the recent formation of a pivot bottom point suggest that CDT stock may be undervalued and due for a rebound, the overall sentiment and technical indicators point to a bearish outlook. Investors should exercise caution and consider these mixed signals when evaluating the stock.